RJ026
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RJ026, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease [Phase 1]